The Royalty-Amassing Strategy Of Royalty Pharma By: Benzinga via Benzinga July 10, 2017 at 16:11 PM EDT Since its 2003 inception, private equity firm Royalty Pharma has built itself not on original research and drug development but on ... Read More >> Related Stocks: AbbVie Biogen Idec HEALTHCARE Johnson & Johnson Merck & Co Perrigo Pfizer Vertex Pharmaceuticals